Skip to main content
METABIOMED.CO.,LTD logo

METABIOMED.CO.,LTD — Investor Relations & Filings

Ticker · 059210 ISIN · KR7059210005 KO Manufacturing
Filings indexed 218 across all filing types
Latest filing 2026-06-11 Capital/Financing Update
Country KR South Korea
Listing KO 059210

About METABIOMED.CO.,LTD

https://www.meta-biomed.com/

METABIOMED.CO.,LTD. is a developer and manufacturer of medical devices and biomaterials. The company's operations are organized into four primary business areas: Dental, Suture Material & Biomaterial, Meta Surgical, and Cosmetic Medical. Its dental division provides a range of equipment and materials, with its root canal filling product holding the largest global market share. The company also manufactures various synthetic absorbable surgical sutures, including Poliglecaprone (PGCL) and Polydioxanone (PDO) types. The surgical division offers devices for use in general surgery, orthopedics, neurosurgery, and obstetrics & gynecology. In the cosmetic medical field, it produces products such as PDO threads. METABIOMED distributes its products to over 100 countries through a global sales network.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 95% confidence The document is a disclosure regarding the company’s acquisition of its own convertible bonds before maturity (i.e., a capital/financing activity altering the company’s debt structure). It provides issuance details, acquisition amounts, funding source, and future handling – fitting the Capital/Financing Update category.
2026-06-11 Welsh
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a Korean ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ (officers & major shareholders specified securities ownership status report), detailing an executive’s shareholdings and on‐market share transactions. This corresponds to a director/insider personal securities transaction filing. Thus the correct classification is Director’s Dealing (DIRS).
2026-06-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 97% confidence The document is a detailed insider ownership report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) filed by an executive, showing personal share transactions and changes in holdings. This matches the definition of Director’s Dealing (insider trades by directors/executives).
2026-05-22 Korean
[기재정정]분기보고서 (2026.03)
Interim / Quarterly Report Classification · 90% confidence The document is titled “분기보고서 … 정정신고” and contains full substantive financial statements and detailed note disclosures for the 2026 Q1 period (allowance for credit losses, inventory schedules, fair value measurements, etc.). It is not merely a notice that a report has been published but the actual corrected interim/quarterly report itself. Under our taxonomy, this is an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a full ‘분기보고서’ (Quarterly Report) for the 1st quarter of fiscal 2026, submitted to the Financial Services Commission and Korea Exchange, containing detailed financial statements, segment results, business overview, capital changes, share transactions, and other substantive quarterly disclosures. It is clearly the company’s interim/quarterly financial report rather than an announcement or summary. Therefore it fits the Interim / Quarterly Report category. Q1 2026
2026-05-15 Korean
[기재정정]주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 92% confidence The document is a Korean "주요사항보고서(자기주식 취득 결정)" describing the company’s decision and detailed parameters for acquiring its own shares (self-share repurchase). It is not a simple announcement of a report nor a certification, but the actual major event disclosure of a share buyback. According to the classification definitions, this falls under “Transaction in Own Shares” (POS).
2026-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.